First, cell surface calreticulin was expressed widely on multiple human cancers (AML, acute lymphoblastic leukemia, chronic myeloid leukemia, non-Hodgkin's lymphoma, bladder and ovarian cancer, and glioblastoma), but was absent on normal cell counterparts. The gene discussed is CALR; the disease is acute myeloid leukemia.